Manufacturing & Supply Chain Transformation
when legacy limits leaner operating models
For the Leaders of Manufacturing Sites and entire Supply Chain operations who find themselves at the epicentre of increasingly complex medicines, rising regulatory scrutiny and expanding manufacturing networks, legacy infrastructure and disconnected operations may no longer be fit for the demands of a leaner, more sustainable manufacturing environment.
But the daily pressures of managing operational issues, site performance and financial targets can leave leadership teams in a permanent state of operating reactively.
Creating the space needed to achieve a leaner and more resilient operating model can be extremely difficult.
That is where we come in.
we've sat in your seat, we know the accountability
While you remain focused on running your business, we apply our deep Pharma operational expertise and manufacturing transformation experience to identify the root causes limiting performance and address the operational challenges that prevent organisations from achieving consistent, sustainable results at scale. We support:
- Site Directors to regain control of operational performance
- Heads of Supply Chain to improve supply resilience and control
- Leaders of high-growth Biotechs to scale from development to commercial reality
Our focus is on quickly solving immediate operational issues, and on enabling scalable growth and long-term transformation. We help establish sustainable ways of working that continue to deliver value long after our engagement has concluded.
Above all, our approach is built around working with organisations rather than doing transformation to them. By developing internal capability, strengthening leadership, and creating ownership within teams, we help ensure improvements are embedded, scalable, and sustainable over the long term.
Our capabilities
Insight Across Modalities and Operating Models
We apply our experience across global life sciences manufacturing and supply chains spanning:
- Small molecule and established biologics operations to emerging modalities such as oligonucleotides and peptides
- API and upstream manufacturing, including internal and externally sourced supply
- Sterile and high-risk manufacturing environments
- Secondary operations and final product presentation
PRIORITISATION & FOCUS WHERE IT MATTERS MOST
Working in partnership, we help you develop a shared, fact-based understanding of:
- Manufacturing and supply network structure, capacity and resilience
- Capability alignment across API, primary manufacture, secondary operations and future modalities
- Safety, quality, compliance and inspection readiness
- Planning effectiveness, inventory and service performance
- Leadership alignment, culture and ways of working
SUPPORTING EXECUTION TODAY AND TOMORROW
Once focus areas are clear, we work alongside leaders and teams to:
- Translate insight into practical, prioritised action
- Stabilise, optimise and transform existing operations for lasting performance
- Address complexity and risk across API, primary manufacture and secondary operations
- Build readiness for new modalities, technologies and product presentations
- Embed sustainability into operational and network decisions
WE CAN DELIVER:
MANUFACTURING & SUPPLY CHAIN STRATEGY
TURNAROUND, TRANSFORMATION & SITE RECOVERY
OPERATIONAL OPTIMISATION
SENIOR LEADERSHIP & CAPABILITY DEVELOPMENT
Process Safety & High-Risk Operation PROTOCOLS
Sustainability Embedded into Manufacturing & Supply Chains
Quality, Compliance, Inspection Readiness
End to end supply chain expertise
Get in touch FOR AN INITIAL DISCOVERY MEETING
Our Clients
